May-21-25 09:00AM
May-13-25 04:05PM
May-09-25 09:00AM
Apr-07-25 09:00AM
Mar-24-25 05:41PM
04:05PM
Loading…
04:05PM
Mar-21-25 09:00AM
Mar-19-25 09:00AM
Mar-13-25 09:00AM
Feb-13-25 09:00AM
Jan-22-25 09:00AM
Jan-02-25 09:00AM
Dec-06-24 08:30AM
Nov-21-24 09:00AM
Nov-13-24 04:40PM
05:35PM
Loading…
Nov-11-24 05:35PM
(GlobeNewswire) +8.02%
-10.00%
09:00AM
Oct-11-24 09:05AM
09:00AM
Oct-10-24 09:00AM
Oct-04-24 09:00AM
Sep-18-24 09:00AM
Aug-14-24 04:25PM
Aug-12-24 09:15AM
09:00AM
Jul-18-24 09:15AM
Jul-08-24 04:05PM
(GlobeNewswire) -7.69%
+9.31%
Jun-27-24 09:00AM
Jun-11-24 08:40AM
May-16-24 09:00AM
08:53PM
Loading…
May-13-24 08:53PM
04:05PM
May-09-24 08:00AM
May-06-24 04:05PM
Apr-29-24 09:00AM
Apr-18-24 08:00AM
Apr-02-24 10:28AM
Apr-01-24 12:52PM
07:50AM
Mar-27-24 09:00AM
Mar-21-24 09:00AM
Mar-11-24 11:00AM
Mar-04-24 08:30AM
Feb-21-24 04:05PM
Jan-18-24 09:00AM
Jan-09-24 08:30AM
Dec-11-23 08:00AM
Dec-05-23 08:00AM
Nov-20-23 10:00AM
Nov-16-23 06:35AM
Nov-13-23 04:05PM
Nov-02-23 09:00AM
Oct-30-23 08:00AM
Sep-26-23 09:49AM
Sep-15-23 11:02AM
Aug-14-23 04:05PM
Aug-11-23 07:01AM
Aug-10-23 06:24AM
Aug-09-23 06:26AM
Aug-08-23 06:28AM
Aug-07-23 06:35AM
Aug-04-23 07:14AM
Aug-03-23 07:15AM
Aug-02-23 09:00AM
07:52AM
Aug-01-23 06:51AM
Jul-31-23 06:44AM
Jul-28-23 07:58AM
Jul-27-23 07:10AM
Jul-26-23 01:12PM
Jul-25-23 07:16AM
Jul-24-23 07:12AM
Jul-21-23 07:23AM
Jul-20-23 06:55AM
Jul-19-23 09:10AM
07:10AM
Jul-18-23 06:53AM
Jul-17-23 07:10AM
Jul-14-23 06:50AM
Jul-13-23 07:02AM
Jul-12-23 07:22AM
Jul-11-23 06:08AM
Jul-10-23 06:56AM
Jul-05-23 06:46AM
Jul-03-23 06:50AM
Jun-30-23 06:52AM
Jun-29-23 06:49AM
Jun-28-23 06:58AM
Jun-27-23 06:46AM
Jun-26-23 06:41AM
Jun-23-23 09:24AM
Jun-22-23 07:05AM
Jun-21-23 07:05AM
Jun-20-23 06:35AM
Jun-15-23 09:00AM
06:38AM
Jun-14-23 06:39AM
Jun-13-23 06:37AM
Jun-12-23 06:47AM
May-24-23 09:00AM
NexGel, Inc. engages in the manufacture of aqueous polymer hydrogels used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. It operates through the NexGel and CGN segments. The NexGel segment consists of the manufacturing of ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, which is based in Langhorne, Pennsylvania. The CGN segment consists of the CGN JV used for the company's converting and packaging business, which is based in Granbury, Texas. The company was founded on January 13, 2009, and is headquartered in Langhorne, PA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Henry Scott Robert Director Jun 13 '25 Sale 2.57 3,000 7,704 129,053 Jun 16 08:00 PM Levy Adam R. Chief Executive Officer Jun 11 '25 Sale 2.39 2,000 4,780 362,284 Jun 11 08:00 PM Levy Adam R. Chief Executive Officer Jun 09 '25 Sale 2.33 2,000 4,659 364,284 Jun 11 08:00 PM Levy Adam R. Chief Executive Officer Jun 05 '25 Sale 2.32 1,000 2,323 366,284 Jun 06 08:00 PM Levy Adam R. Chief Executive Officer Jun 04 '25 Sale 2.29 1,000 2,290 367,284 Jun 06 08:00 PM Levy Adam R. Chief Executive Officer May 30 '25 Sale 2.22 1,000 2,220 368,284 Jun 02 08:00 PM Levy Adam R. Chief Executive Officer May 16 '25 Sale 2.58 1,000 2,575 369,284 May 20 08:00 PM Levy Adam R. Officer May 16 '25 Proposed Sale 2.37 8,000 18,960 May 16 10:41 AM Henry Scott Robert Director May 12 '25 Sale 2.69 3,000 8,062 132,053 May 13 08:00 PM Henry Scott Robert Director Apr 10 '25 Sale 2.61 3,000 7,825 135,053 Apr 14 05:00 PM Henry Scott Robert Director Apr 10 '25 Proposed Sale 2.60 9,000 23,400 Apr 10 10:37 AM Levy Adam R. Chief Executive Officer Apr 01 '25 Sale 3.01 4,000 12,038 370,284 Apr 02 05:00 PM Henry Scott Robert Director Mar 10 '25 Sale 2.87 3,000 8,621 138,053 Mar 11 05:00 PM Levy Adam R. Chief Executive Officer Mar 03 '25 Sale 3.16 4,000 12,639 374,284 Mar 05 05:00 PM Henry Scott Robert Director Feb 10 '25 Sale 3.27 3,000 9,798 138,553 Feb 12 05:00 PM Levy Adam R. Chief Executive Officer Feb 03 '25 Sale 3.64 4,000 14,558 378,284 Feb 05 05:00 PM Henry Scott Robert Director Jan 07 '25 Sale 3.37 3,000 10,096 141,553 Jan 08 04:30 PM Levy Adam R. Chief Executive Officer Jan 02 '25 Sale 3.96 4,000 15,828 382,284 Jan 06 04:37 PM Levy Adam R. Officer Jan 02 '25 Proposed Sale 4.03 16,000 64,480 Jan 02 11:49 AM Henry Scott Robert Director Dec 20 '24 Sale 4.64 3,000 13,935 144,553 Dec 23 05:00 PM Henry Scott Robert Director Dec 20 '24 Proposed Sale 4.63 12,000 55,620 Dec 20 10:11 AM Henry Scott Robert Director Nov 20 '24 Buy 2.75 1,818 5,000 147,553 Nov 22 04:54 PM Levy Adam R. Chief Executive Officer Nov 20 '24 Buy 2.75 3,636 9,999 333,196 Nov 22 04:54 PM ZELDIS JEROME B Director Nov 20 '24 Buy 2.75 3,636 9,999 106,664 Nov 22 04:54 PM Drapczuk Adam E III Chief Financial Officer Nov 20 '24 Buy 2.75 17,500 48,125 74,894 Nov 22 04:54 PM glassman steven mark Director Nov 20 '24 Buy 2.75 9,090 24,998 154,155 Nov 22 04:54 PM Stein John Nachum Director Nov 20 '24 Buy 2.75 3,636 9,999 471,456 Nov 22 04:54 PM Stein John Nachum Director Aug 23 '24 Buy 2.50 10,000 25,000 471,820 Aug 28 05:00 PM glassman steven mark Director Aug 23 '24 Buy 2.50 10,000 25,000 145,025 Aug 27 09:14 PM ZELDIS JEROME B Director Aug 23 '24 Buy 2.50 10,000 25,000 103,028 Aug 27 09:13 PM Henry Scott Robert Director Aug 23 '24 Buy 2.50 10,000 25,000 145,735 Aug 27 09:11 PM Drapczuk Adam E III Chief Financial Officer Aug 23 '24 Buy 2.50 10,000 25,000 57,394 Aug 27 09:09 PM